News

FDA Enforcement and Related Litigation: Responding to FDA and Minimizing Criminal and Civil Litigation Risk

Wednesday, March 31, 2021
Arnold & Porter Webinar

What should a company do after it receives adverse FDA inspection observations or otherwise faces FDA enforcement?

This webinar outlines the types of FDA enforcement actions, agency considerations for taking action, and ways companies should engage with FDA and try to avoid more serious enforcement, to include Justice Department civil litigation and criminal investigations. Since a company's initial response to an inspection or other FDA compliance issue can increase or reduce legal risk in other settings, we will also outline the risks from private litigation that often accompany FDA enforcement, such as mass tort actions and civil False Claims Act suits.

Finally, we address the Biden-Harris Administration enforcement agenda and policy trends in this area.

Meet the Speakers

Mahnu V. Davar
Partner
Arnold & Porter
Daniel A. Kracov
Partner
Arnold & Porter
Howard Sklamberg
Partner
Arnold & Porter
Raqiyyah Pippins
Partner
Arnold & Porter
Anna K. Thompson
Counsel
Arnold & Porter
Subscribe
Subscribe Link

Email Disclaimer